Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RITE: PL2200 vs Enteric-Coated Aspirin in Type 2 Diabetes
NCT02008942Phase 3Completed
- Sponsor
- PLx Pharma Inc.
- Start
- Jan 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omecamtiv mecarbil in cardiovascular disease (CVD), thrombosis, sponsored by PLx Pharma Inc.. Started Jan 2014; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
cardiovascular disease (CVD)thrombosis
Beyond the preview
Go deeper on NCT02008942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008942.